A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation

Specialty Areas:
Date: June 28, 2023
Authors:
Kelsey T Danley, Karen Schmitz, Ritu Ghai, Joy S Sclamberg, Lela E Buckingham, Kelly Burgess, Timothy Kuzel, Lydia Usha
Journal: The Oncologist
Journal Volume: 26